CSIMarket


Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Evolutionary Genomics Inc

FNAM's Fundamental analysis








Evolutionary Genomics Inc 's sales fell in IV. Quarter 2022 from the same quarter a year ago.

Medical Laboratories industry recorded deterioration of revenues by -3.05 %

Evolutionary Genomics Inc net loss deacreased by in IV. Quarter 2022 year on year, Evolutionary Genomics Inc net loss increased by -85.25 % in IV. Quarter 2022 year on year,

More on FNAM's Growth


Evolutionary Genomics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 12.39 in trailing twelve-month period. Medical Laboratories industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-0
PE TTM    
Medical Laboratories industry's Price to Sales ratio is at 3.


More on FNAM's Valuation
 
 Total Debt (Millions $) 4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -1.13

Evolutionary Genomics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 12.39 in trailing twelve-month period. Medical Laboratories industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-0
PE TTM    
Medical Laboratories industry's Price to Sales ratio is at 3.


More on FNAM's Valuation

  Market Capitalization (Millions $) 5
  Shares Outstanding (Millions) 6
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -2
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) 4
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) -1.13

  Market Capitalization (Millions $) 5
  Shares Outstanding (Millions) 6
  Employees -
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -2
  Cash Flow (TTM) (Millions $) 0
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 0.35
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com